Impact of Kinesiophobia on Descending Corticospinal and Bulbospinal Projections
EchoKinésio
1 other identifier
interventional
24
1 country
1
Brief Summary
Fear of movement (kinesiophobia) is a phenomenon commonly observed in people suffering from chronic pain. The aims of this project are to better understand the neurophysiological basis of this phenomenon, in particular 1) the effect of kinesiophobia (induced by nocebo intervention) on the excitability of corticospinal projections and 2) the association between kinesiophobia and top-down inhibitory mechanisms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 26, 2021
CompletedFirst Posted
Study publicly available on registry
December 17, 2021
CompletedStudy Start
First participant enrolled
January 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 29, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 29, 2024
CompletedJune 5, 2024
June 1, 2024
1.5 years
November 26, 2021
June 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Corticospinal excitability
The corticospinal excitability will be assessed using motor evoked potentials at different intensity of stimulation (from motor threshold to maximal amplitude response).
1 hour
Secondary Outcomes (1)
downward inhibition of pain
1 hour
Study Arms (2)
nocebo
EXPERIMENTALUltrasound with fake results of rotator cuff injury.
placebo
ACTIVE COMPARATORUltrasound with fake results of the healthy rotator cuff.
Interventions
Eligibility Criteria
You may qualify if:
- Aged 18 years old or older
- Healthy Volunteers
- Capable of understanding instructions
- Abstain from tobacco and caffeine 2 hours before data collection
- Abstain from short-acting analgesics 6 hours before data collection
You may not qualify if:
- A painful condition or chronic pain
- Neurological disorders
- Shoulder pathology
- Skin diseases
- Capsaicin allergy
- Raynaud's syndrome
- Epilepsy
- Intracranial metallic foreign bodies, hearing aids and cochlear implants
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre de Recherche sur le Vieillissement
Sherbrooke, Quebec, J1H 4C4, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Guillaume Leonard, Pr
Université de Sherbrooke
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- The principal investigators will be blinded by anonymization of the subjects and will not be present during the ultrasound. Participants will be notified of their group allocation at the end of their experimental session (after the experiment).
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 26, 2021
First Posted
December 17, 2021
Study Start
January 15, 2022
Primary Completion
July 29, 2023
Study Completion
January 29, 2024
Last Updated
June 5, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share